Australian healthcare industry: M&A and capital markets update

This publication was released 1 October 2020.

Despite being poised for future growth the Australian Healthcare industry finds itself at an interesting crossroads.

In the last six months, Australia's healthcare industry had undergone considerable change as governments, businesses and wider society respond to the sudden challenges posed by the outbreak of COVID-19.

However, many of these changes to Australian healthcare have long been in the making as the intersection of technology, consumer demands and the revelation that patients will be able to target their conditions before they become advanced, bring the opportunity of a new emerging model.

Yet, with fundamental change, there are also macro implications – including the right legal and regulatory compliance, and also, a skilled workforce to adapt to the change.

In this extended edition of BDO's Healthcare Highlights, our experts across the country take a deep dive into the Australian Healthcare Industry exploring its composition, trading and performance as well as sharing comprehensive insights into recent Australian M&A deal activity.

What’s covered in this extended edition of BDO’s healthcare highlights?

  • Key drivers for change
  • Macroeconomic environment
  • Healthcare on the ASX
  • M&A activity
  • Capital raises
  • Sub-sectors in the spotlight (telehealth, aged care and biotechnology) 

Download BDO's Healthcare Highlights

For more information, contact your local office.